Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
8.678 EUR | -2.84% | -8.25% | -57.64% |
09-02 | Forvia : Templeton GA Ltd falls below 5% of share capital | CF |
08-27 | Forvia : Templeton Global Advisors Ltd below 5% of voting rights | CF |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 17.77B | 14.65B | 15.62B | 25.46B | 27.25B | |||||
Total Revenues | 17.77B | 14.65B | 15.62B | 25.46B | 27.25B | |||||
Cost of Goods Sold, Total | 15.29B | 13.18B | 13.73B | 22.23B | 23.59B | |||||
Gross Profit | 2.48B | 1.47B | 1.88B | 3.22B | 3.66B | |||||
Selling General & Admin Expenses, Total | 787M | 732M | 695M | 1.22B | 1.29B | |||||
R&D Expenses | 420M | 342M | 331M | 897M | 953M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 56.4M | 91.7M | 92.6M | 219M | 193M | |||||
Other Operating Expenses, Total | 1.26B | 1.17B | 1.12B | 2.34B | 2.44B | |||||
Operating Income | 1.22B | 309M | 765M | 885M | 1.22B | |||||
Interest Expense, Total | -198M | -204M | -239M | -385M | -586M | |||||
Interest And Investment Income | 18.7M | 18.1M | 32M | 51.6M | 90.7M | |||||
Net Interest Expenses | -179M | -186M | -207M | -334M | -496M | |||||
Income (Loss) On Equity Invest. | 37.8M | -12.8M | -24.6M | 11.4M | -2.2M | |||||
Currency Exchange Gains (Loss) | -4.1M | -8.1M | -1.1M | -44.9M | -43.3M | |||||
Other Non Operating Income (Expenses) | -28.3M | -17.3M | -18.7M | -57.6M | 134M | |||||
EBT, Excl. Unusual Items | 1.04B | 84.3M | 513M | 460M | 816M | |||||
Restructuring Charges | -194M | -286M | -196M | -352M | -171M | |||||
Merger & Related Restructuring Charges | - | - | -37M | -77.3M | - | |||||
Impairment of Goodwill | - | -150M | - | - | - | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | - | |||||
Asset Writedown | 700K | -16.5M | - | - | 1.8M | |||||
Legal Settlements | - | - | - | - | - | |||||
Other Unusual Items | -20.3M | 170M | -28.1M | -95.2M | -43.9M | |||||
EBT, Incl. Unusual Items | 832M | -198M | 252M | -64.1M | 603M | |||||
Income Tax Expense | 167M | 123M | 139M | 186M | 232M | |||||
Earnings From Continuing Operations | 665M | -322M | 113M | -250M | 371M | |||||
Earnings Of Discontinued Operations | - | - | -96.5M | - | -5.4M | |||||
Net Income to Company | 665M | -322M | 16.2M | -250M | 366M | |||||
Minority Interest | -75M | -57.3M | -95M | -131M | -143M | |||||
Net Income - (IS) | 590M | -379M | -78.8M | -382M | 222M | |||||
Net Income to Common Incl Extra Items | 590M | -379M | -78.8M | -382M | 222M | |||||
Net Income to Common Excl. Extra Items | 590M | -379M | 17.7M | -382M | 228M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 4.31 | -2.75 | -0.57 | -2.2 | 1.13 | |||||
Basic EPS - Continuing Operations | 4.31 | -2.75 | 0.13 | -2.2 | 1.15 | |||||
Basic Weighted Average Shares Outstanding | 137M | 138M | 138M | 174M | 197M | |||||
Net EPS - Diluted | 4.29 | -2.75 | -0.57 | -2.2 | 1.12 | |||||
Diluted EPS - Continuing Operations | 4.29 | -2.75 | 0.13 | -2.2 | 1.15 | |||||
Diluted Weighted Average Shares Outstanding | 138M | 138M | 138M | 174M | 198M | |||||
Normalized Basic EPS | 4.22 | -0.03 | 1.64 | 0.9 | 1.86 | |||||
Normalized Diluted EPS | 4.2 | -0.03 | 1.64 | 0.9 | 1.86 | |||||
Dividend Per Share | 1.3 | 1 | - | - | 0.5 | |||||
Payout Ratio | 28.86 | - | -171.07 | - | - | |||||
American Depositary Receipts Ratio (ADR) | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | |||||
Supplemental Items | ||||||||||
EBITDA | 1.76B | 875M | 1.32B | 1.73B | 2.31B | |||||
EBITA | 1.28B | 400M | 857M | 885M | 1.46B | |||||
EBIT | 1.22B | 309M | 765M | 885M | 1.22B | |||||
Effective Tax Rate - (Ratio) | 20.06 | -62.29 | 55.19 | -290.64 | 38.52 | |||||
Total Current Taxes | 243M | 181M | 234M | 368M | 414M | |||||
Total Deferred Taxes | -76.5M | -57.8M | -95M | -181M | -182M | |||||
Normalized Net Income | 578M | -4.61M | 226M | 156M | 367M | |||||
Interest on Long-Term Debt | 45.5M | 48.4M | 45.5M | 53.9M | 58.8M | |||||
Non-Cash Pension Expense | -8.8M | 5.3M | -100K | 7.2M | 22.1M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 858M | 852M | 838M | 1.58B | 1.64B | |||||
Stock-Based Comp., Other (Total) | 18.9M | 15.8M | 3.9M | 16.4M | - | |||||
Total Stock-Based Compensation | 18.9M | 15.8M | 3.9M | 16.4M | - |